PMID- 27556823 OWN - NLM STAT- MEDLINE DCOM- 20190624 LR - 20190624 IS - 1533-4058 (Electronic) IS - 1533-4058 (Linking) VI - 26 IP - 5 DP - 2018 May/Jun TI - Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification. PG - 316-323 LID - 10.1097/PAI.0000000000000435 [doi] AB - Little is known about the aminopeptidase CD13 in renal neoplasia according to the new 2016 World Health Organization renal tumor classification. We selected 175 cases, including 79 clear cell, 31 papillary, 24 chromophobe, 8 clear cell papillary renal cell carcinomas (RCCs), 21 oncoytomas, and 12 microphthalmia transcription factor family translocation RCCs: 4 t(6;11)/transcription factor EB (TFEB), 7 t(Xp11) with 2 cystic variants and 1 t(X;17). GATA binding protein 3 (GATA-3) was inserted as control. Expression of proximal antigen CD13 was observed in 63/79 (80%) clear cell, 25/31 (81%) papillary, 3/8 (37%) clear cell papillary, 1/4 (25%) t(6;11)/TFEB, 2/7 (28%) cystic t(Xp11), and in 1/1 t(X;17) RCCs. All chromophobe RCC (0/24) and all oncocytomas (0/21) resulted negative. CD10 was seen in 76/79 (96%) clear cell, 15/31 (48%) papillary, 10/24 (42%) chromophobe, 1/8 (12%) clear cell papillary RCCs, 4/21 (19%) oncocytomas, 1/4 (25%) t(6;11)/TFEB, 2/7 (29%) cystic t(Xp11), and in 1/1 t(X;17) RCCs. GATA-3 was positive in 3/7 (42%) clear cell papillary RCCs and negative in all remaining RCCs, except a single chromophobe RCC and a single oncocytoma. We concluded that: (1) CD13 and GATA-3 immunostains may serve as a diagnostic aid in differentiating subtypes of RCC; (2) CD13 is always absent in chromophobe RCC and oncocytomas, whereas CD10 can be immunoexpressed in both; (3) CD13 should be included in a panel of antibodies to distinguish "proximal renal tumors" from "distal renal tumors" and between clear cell RCC versus microphthalmia transcription factor family translocations RCCs; and (4) when present, GATA-3 is specific for clear cell papillary RCC. FAU - Brunelli, Matteo AU - Brunelli M AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Erdini, Francesco AU - Erdini F AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Cima, Luca AU - Cima L AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Eccher, Albino AU - Eccher A AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Fioravanzo, Adele AU - Fioravanzo A AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Gobbo, Stefano AU - Gobbo S AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Segala, Diego AU - Segala D AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Ghimenton, Claudio AU - Ghimenton C AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Mazzoleni, Guido AU - Mazzoleni G AD - Pathology Unit, San Maurizio Hospital, Bolzano. FAU - Munari, Enrico AU - Munari E AD - Department of Diagnostics and Public Health, University of Verona, Verona. FAU - Carella, Rodolfo AU - Carella R AD - Pathology Unit, San Maurizio Hospital, Bolzano. FAU - Martignoni, Guido AU - Martignoni G AD - Department of Diagnostics and Public Health, University of Verona, Verona. AD - Pathology Unit, Pederzoli Hospital, Peschiera Del Garda, Italy. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Appl Immunohistochem Mol Morphol JT - Applied immunohistochemistry & molecular morphology : AIMM JID - 100888796 RN - 0 (Basic Helix-Loop-Helix Leucine Zipper Transcription Factors) RN - 0 (Biomarkers, Tumor) RN - 0 (GATA3 Transcription Factor) RN - 0 (GATA3 protein, human) RN - 0 (TFEB protein, human) RN - EC 3.4.11.2 (CD13 Antigens) SB - IM MH - Adenoma, Oxyphilic/*diagnosis MH - Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics MH - Biomarkers, Tumor/*metabolism MH - CD13 Antigens/*metabolism MH - Carcinoma, Papillary/*diagnosis MH - Carcinoma, Renal Cell/*diagnosis MH - Diagnosis, Differential MH - GATA3 Transcription Factor/*metabolism MH - Humans MH - Immunochemistry MH - Kidney Neoplasms/*diagnosis MH - Male MH - Translocation, Genetic MH - World Health Organization EDAT- 2016/08/25 06:00 MHDA- 2019/06/25 06:00 CRDT- 2016/08/25 06:00 PHST- 2016/08/25 06:00 [pubmed] PHST- 2019/06/25 06:00 [medline] PHST- 2016/08/25 06:00 [entrez] AID - 10.1097/PAI.0000000000000435 [doi] PST - ppublish SO - Appl Immunohistochem Mol Morphol. 2018 May/Jun;26(5):316-323. doi: 10.1097/PAI.0000000000000435.